Press release | 11th July 2007
IDBS Renews Participation in SAFE-BioPharma Association's Vendor Partner Program
Guildford, UK, July 11, 2007 – IDBS, a leading Electronic Laboratory Notebook (ELN) provider, today announced it has renewed its participation in the SAFE-BioPharma Association Vendor Partner Program. SAFE creates and manages the SAFE™ digital identity and digital signature standard used within the pharmaceutical industry.
IDBS was the first Electronic Lab Notebook (ELN) vendor to join the SAFE Vendor Partner Program when it adopted the SAFE standard in 2006 as part of its E-WorkBook Suite. The company integrated the SAFE standard into its E-WorkBook Suite allowing scientists and others in the life science industry to capture, protect and exchange research data in a secure and compliant environment.
“IDBS is proud to be working with SAFE to provide an industry-leading ELN solution,” commented Neil Kipling, founder and CEO of IDBS. “Pharmaceutical companies are increasingly demanding robust, externally validated systems to deliver regulatory compliance and IP protection. IDBS has taken the lead in meeting this need through the implementation of the SAFE standard into the E-WorkBook Suite.”
“We are delighted that IDBS is reaffirming its commitment to the SAFE Vendor Partner Program,” said Mollie Shields-Uehling, president and CEO of SAFE-BioPharma Association. “IDBS is a valued participant in the expanding SAFE community, and will continue to play a key role in providing companies with a reliable method of IP protection and regulatory compliance.”
About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE™ digital identity and digital signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. SAFE stands for “Signatures and Authentication For Everyone.” The Association’s founder-members include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, and Sanofi-Aventis.
For more information, visit http://www.safe-biopharma.org.
SAFE™ is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
More news
Ensuring product, process and patient data integrity and traceability throughout the BioPharmaceutical lifecycle in the era of personalized medicine
The BioPharma industry is facing a multitude of challenging external trends, from the growth in personalized medicine to supply chain disruptions and more.
European Biomanufacturing Summit 2023
Come and join us at booth 130 in Amsterdam, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
IDBS events roundup: Q1 highlights and Q2 events
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
How to improve time-to-value using GxP computer systems
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.